529 related articles for article (PubMed ID: 27138961)
1. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
Haacker M; Fraser-Hurt N; Gorgens M
PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
[TBL] [Abstract][Full Text] [Related]
2. Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography.
Kripke K; Chimbwandira F; Mwandi Z; Matchere F; Schnure M; Reed J; Castor D; Sgaier S; Njeuhmeli E
PLoS One; 2016; 11(7):e0156521. PubMed ID: 27410474
[TBL] [Abstract][Full Text] [Related]
3. Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.
Kripke K; Chen PA; Vazzano A; Thambinayagam A; Pillay Y; Loykissoonlal D; Bonnecwe C; Barron P; Kiwango E; Castor D; Njeuhmeli E
PLoS One; 2016; 11(7):e0157071. PubMed ID: 27409079
[TBL] [Abstract][Full Text] [Related]
4. The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania.
Kripke K; Perales N; Lija J; Fimbo B; Mlanga E; Mahler H; Juma JM; Baingana E; Plotkin M; Kakiziba D; Semini I; Castor D; Njeuhmeli E
PLoS One; 2016; 11(7):e0153363. PubMed ID: 27410384
[TBL] [Abstract][Full Text] [Related]
5. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.
Njeuhmeli E; Forsythe S; Reed J; Opuni M; Bollinger L; Heard N; Castor D; Stover J; Farley T; Menon V; Hankins C
PLoS Med; 2011 Nov; 8(11):e1001132. PubMed ID: 22140367
[TBL] [Abstract][Full Text] [Related]
6. Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography.
Hankins C; Warren M; Njeuhmeli E
PLoS One; 2016; 11(10):e0160699. PubMed ID: 27783613
[TBL] [Abstract][Full Text] [Related]
7. Age targeting and scale-up of voluntary medical male circumcision in Mozambique.
Dent J; Gaspar N; Njeuhmeli E; Kripke K
PLoS One; 2019; 14(2):e0211958. PubMed ID: 30794561
[TBL] [Abstract][Full Text] [Related]
8. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
[TBL] [Abstract][Full Text] [Related]
9. Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.
Kripke K; Opuni M; Schnure M; Sgaier S; Castor D; Reed J; Njeuhmeli E; Stover J
PLoS One; 2016; 11(7):e0156909. PubMed ID: 27410966
[TBL] [Abstract][Full Text] [Related]
10. Could Circumcision of HIV-Positive Males Benefit Voluntary Medical Male Circumcision Programs in Africa? Mathematical Modeling Analysis.
Awad SF; Sgaier SK; Lau FK; Mohamoud YA; Tambatamba BC; Kripke KE; Thomas AG; Bock N; Reed JB; Njeuhmeli E; Abu-Raddad LJ
PLoS One; 2017; 12(1):e0170641. PubMed ID: 28118387
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the cost of adult voluntary medical male circumcision in a mixed (surgical and PrePex) site compared to a hypothetical PrePex-only site in South Africa.
Kim HY; Lebina L; Milovanovic M; Taruberekera N; Dowdy DW; Martinson NA
Glob Health Action; 2015; 8():29116. PubMed ID: 26679407
[TBL] [Abstract][Full Text] [Related]
12. Modeling Impact and Cost-Effectiveness of Increased Efforts to Attract Voluntary Medical Male Circumcision Clients Ages 20-29 in Zimbabwe.
Kripke K; Hatzold K; Mugurungi O; Ncube G; Xaba S; Gold E; Ahanda KS; Kruse-Levy N; Njeuhmeli E
PLoS One; 2016; 11(10):e0164144. PubMed ID: 27783637
[TBL] [Abstract][Full Text] [Related]
13. Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia.
Awad SF; Sgaier SK; Tambatamba BC; Mohamoud YA; Lau FK; Reed JB; Njeuhmeli E; Abu-Raddad LJ
PLoS One; 2015; 10(12):e0145729. PubMed ID: 26716442
[TBL] [Abstract][Full Text] [Related]
14. Voluntary medical male circumcision service delivery in South Africa: The economic costs and potential opportunity for private sector involvement.
Tchuenche M; Njeuhmeli E; Schütte C; Ngubeni L; Choge I; Martin E; Loykissoonlal D; Kiggundu V; Yansaneh A; Forsythe S
PLoS One; 2018; 13(12):e0208698. PubMed ID: 30557330
[TBL] [Abstract][Full Text] [Related]
15. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
Binagwaho A; Pegurri E; Muita J; Bertozzi S
PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
[TBL] [Abstract][Full Text] [Related]
16. Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting.
Kripke K; Okello V; Maziya V; Benzerga W; Mirira M; Gold E; Schnure M; Sgaier S; Castor D; Reed J; Njeuhmeli E
PLoS One; 2016; 11(7):e0156776. PubMed ID: 27410687
[TBL] [Abstract][Full Text] [Related]
17. Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program.
Njeuhmeli E; Stegman P; Kripke K; Mugurungi O; Ncube G; Xaba S; Hatzold K; Christensen A; Stover J
PLoS One; 2016; 11(7):e0159167. PubMed ID: 27410233
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of male circumcision for HIV prevention in a South African setting.
Kahn JG; Marseille E; Auvert B
PLoS Med; 2006 Dec; 3(12):e517. PubMed ID: 17194197
[TBL] [Abstract][Full Text] [Related]
19. Voluntary Medical Male Circumcision to Prevent HIV: Modelling Age Prioritization in Namibia.
Stegman P; Stirling B; Corner B; Schnure M; Mali D; Shihepo E; Kripke K; Njeuhmeli E
AIDS Behav; 2019 Sep; 23(Suppl 2):195-205. PubMed ID: 31214866
[TBL] [Abstract][Full Text] [Related]
20. The cost of demand creation activities and voluntary medical male circumcision targeting school-going adolescents in KwaZulu-Natal, South Africa.
George G; Strauss M; Asfaw E
PLoS One; 2017; 12(6):e0179854. PubMed ID: 28632768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
